Abstract
Background: A major portion of poultry feather waste is constituted by keratin, which is recalcitrant to degradation by common proteases. Feather waste contributes to a significant volume of biowaste load to the environment. Valorization of these wastes into various products has been attempted by many researchers. The present study aimed to produce peptides (molecular weight < 10 kDa) from feather waste by the action of keratinolytic bacteria or keratinase enzyme and to screen the peptides for pharmaceutical and therapeutic properties. The feathers were subjected to hydrolysis by using locally isolated keratinolytic microorganisms, namely Streptomyces tanashiensis-RCM-SSR-6, Bacillus sp. RCM-SSR-102, and purified keratinase enzyme KER-102.
Results: The feather keratin hydrolysate obtained by hydrolysis with different bacterial species/enzymes showed different protein profiles in SDS-PAGE. As indicated by Fourier Transform Infrared Spectroscopy (FTIR) analysis, a difference was observed in the composition of α-helix and β-sheet in the peptides produced by different microbial/enzymatic methods. The peptides were screened for antioxidant potential, antityrosinase property, and inhibitory activity against angiotensin-converting enzyme (ACE), lipoxygenase, and xanthine oxidase. The peptides showed promising results in all the assays, except peptide-102 that did not show ACE inhibitory activity. Interestingly, the crude peptide-6 (4.06 µg/mL) and peptide-102 (10.21 µg/mL) showed a lower EC50 value than the standard Kojic acid (27.04 µg/mL) in antityrosinase assay.
Conclusions: Degradation of chicken feather waste with microbial or enzymatic method is an eco-friendly approach to yield diverse bioactive peptides. Hence, the present study established that feather keratin could be a potential source of many health-beneficial peptides.
Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".
The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.